Diagnostic and Prognostic Biomarkers in Parkinson Disease

Status unconfirmed

Conditions studied: Parkinson Disease, Multiple System Atrophy, Progressive Supranuclear Palsy

In brief

The overall goal of PROBE is to evaluate the feasibility and potential utility of three markers (alpha-synuclein, transcriptomic profiles and olfactory function) to determine the risk or prognosis of PD.

Key facts

Study ID

NCT00653783

Run by

The Parkinson Study Group

People needed

200

Starts

2007-08-01

Last updated by the study team

2008-12-31

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

Where it is running

• Parkinson Study Group — Rochester, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.